134 related articles for article (PubMed ID: 36943357)
1. Comment on: Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database.
Ciaffi J; Liem SIE; van Leeuwen NM; Allaart CF; Huizinga TWJ; de Vries-Bouwstra JK
Rheumatology (Oxford); 2023 Aug; 62(8):e251-e253. PubMed ID: 36943357
[No Abstract] [Full Text] [Related]
2. Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database.
Iudici M; Mongin D; Siegert E; Carreira PE; Distler J; Henes J; Zanatta E; Hachulla E; De Luca G; de Souza Müller C; Santiago T; Tandaipan JL; Valdetaro Bianchi B; De Santis M; Hoffmann-Vold AM; Gabrielli A; Distler O; Courvoisier DS;
Rheumatology (Oxford); 2023 Apr; 62(4):1559-1567. PubMed ID: 36099040
[TBL] [Abstract][Full Text] [Related]
3. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials And Research (EUSTAR) group database.
Tyndall A; Mueller-Ladner U; Matucci-Cerinic M
Ann Rheum Dis; 2005 Jul; 64(7):1107. PubMed ID: 15958775
[No Abstract] [Full Text] [Related]
5. Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center.
Bruni C; Praino E; Guiducci S; Bellando-Randone S; Furst DE; Matucci-Cerinic M
Joint Bone Spine; 2017 Dec; 84(6):747-748. PubMed ID: 27932280
[No Abstract] [Full Text] [Related]
6. The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research.
Tyndall A; Ladner UM; Matucci-Cerinic M
Curr Opin Rheumatol; 2008 Nov; 20(6):703-6. PubMed ID: 18946332
[TBL] [Abstract][Full Text] [Related]
7. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
Avouac J; Kowal-Bielecka O; Landewe R; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
[TBL] [Abstract][Full Text] [Related]
8. Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?
Müller-Ladner U; Tyndall A; Czirjak L; Denton C; Matucci-Cerinic M;
Ann Rheum Dis; 2014 Feb; 73(2):324-7. PubMed ID: 24121165
[TBL] [Abstract][Full Text] [Related]
9. Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database.
Ingegnoli F; Ardoino I; Boracchi P; Cutolo M;
Microvasc Res; 2013 Sep; 89():122-8. PubMed ID: 23792167
[TBL] [Abstract][Full Text] [Related]
10. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.
Meier FM; Frommer KW; Dinser R; Walker UA; Czirjak L; Denton CP; Allanore Y; Distler O; Riemekasten G; Valentini G; Müller-Ladner U;
Ann Rheum Dis; 2012 Aug; 71(8):1355-60. PubMed ID: 22615460
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.
Avouac J; Walker U; Tyndall A; Kahan A; Matucci-Cerinic M; Allanore Y; ; Miniati I; Muller A; Iannone F; Distler O; Becvar R; Sierakowsky S; Kowal-Bielecka O; Coelho P; Cabane J; Cutolo M; Shoenfeld Y; Valentini G; Rovensky J; Riemekasten G; Vlachoyiannopoulos P; Caporali R; Jiri S; Inanc M; Zimmermann Gorska I; Carreira P; Novak S; Czirjak L; Oliveira Ramos F; Jendro M; Chizzolini C; Kucharz EJ; Richter J; Cozzi F; Rozman B; Mallia CM; Gabrielli A; Farge D; Kiener HP; Schöffel D; Airo P; Wollheim F; Martinovic D; Trotta F; Jablonska S; Reich K; Bombardieri S; Siakka P; Pellerito R; Bambara LM; Morovic-Vergles J; Denton C; Hinrichs R; Van den Hoogen F; Damjanov N; Kötter I; Ortiz V; Heitmann S; Krasowska D; Seidel M; Hasler P; Van Laar JM; Kaltwasser JP; Foeldvari I; Juan Mas A; Bajocchi G; Wislowska M; Pereira Da Silva JA; Jacobsen S; Worm M; Graniger W; Kuhn A; Stankovic A; Cossutta R; Majdan M; Damjanovska Rajcevska L; Tikly M; Nasonov EL; Steinbrink K; Herrick A; Müller-Ladner U; Dinc A; Scorza R; Sondergaard K; Indiveri F; Nielsen H; Szekanecz Z; Silver RM; Antivalle M; Espinosa IB; García de la Pena Lefebvre P; Midtvedt O; Launay D; Valesini F; Tuvik P; Ionescu RM; Del Papa N; Pinto S; Wigley F; Mihai C; Sinziana Capranu M; Sunderkötter C; Jun JB; Alhasani S; Distler JH; Ton E; Soukup T; Seibold J; Zeni S; Nash P; Mouthon L; De Keyser F; Duruöz MT; Cantatore FP; Strauss G; von Mülhen CA; Pozzi MR; Eyerich K; Szechinski J; Keiserman M; Houssiau FA; Román-Ivorra JA; Krummel-Lorenz B; Aringer M; Westhovens R; Bellisai F; Mayer M; Stoeckl F; Uprus M; Volpe A; Buslau M; Yavuz S; Granel B; Valderílio Feijó A; Del Galdo F; Popa S; Zenone T; Ricardo Machado X; Pileckyte M; Stebbings S; Mathieu A; Tulli A; Tourinho T; Souza R; Acayaba de Toledo R; Stamp L; Solanki K; Veale D; Francisco Marques Neto J; Bagnato GF; Loyo E; Toloza S; Li M; Ahmed Abdel Atty Mohamed W; Cobankara V; Olas J; Salsano F; Oksel F; Tanaseanu CM; Foti R; Ancuta C; Vonk M; Caramashi P; Beretta L; Balbir A; Chiàla A; Pasalic Simic K; Ghio M; Stamenkovic B; Rednic S; Host N; Pellerito R; Hachulla E; Furst DE
J Rheumatol; 2010 Jul; 37(7):1488-501. PubMed ID: 20551097
[TBL] [Abstract][Full Text] [Related]
12. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
[TBL] [Abstract][Full Text] [Related]
13. What should clinicians know about the use of glucocorticoids in systemic sclerosis?
Iudici M
Mod Rheumatol; 2017 Nov; 27(6):919-923. PubMed ID: 28058863
[TBL] [Abstract][Full Text] [Related]
14. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients.
Benvenuti F; Zanatta E; Avouac J; Müller-Ladner U; Cozzi F; Hoffmann-Vold AM; Gabrielli A; Distler O; Matucci-Cerinic M; Allanore Y; Doria A
Expert Rev Clin Immunol; 2020 Nov; 16(11):1065-1074. PubMed ID: 33076716
[TBL] [Abstract][Full Text] [Related]
15. Peristomal morphoea in a patient with systemic sclerosis.
Jiang KW; Zagarella SS; Chan L; Harris A
Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
[No Abstract] [Full Text] [Related]
16. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
Pellar RE; Pope JE
Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339
[TBL] [Abstract][Full Text] [Related]
17. NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity.
Pignataro F; Maglione W; Minniti A; Sambataro D; Sambataro G; Campanaro F; Valentini G; Vitali C; Del Papa N
Arthritis Res Ther; 2019 Nov; 21(1):258. PubMed ID: 31783890
[TBL] [Abstract][Full Text] [Related]
18. Do We Have Good Activity Indices in Systemic Sclerosis?
Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.
Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA;
Ann Rheum Dis; 2016 Jul; 75(7):1285-92. PubMed ID: 26232495
[TBL] [Abstract][Full Text] [Related]
20. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
Tanahashi K; Sugiura K; Muro Y; Akiyama M
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
